Home/Filings/4/0000899243-22-025741
4//SEC Filing

Doebele Robert 4

Accession 0000899243-22-025741

CIK 0001724979other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 6:02 PM ET

Size

6.9 KB

Accession

0000899243-22-025741

Insider Transaction Report

Form 4
Period: 2022-07-06
Doebele Robert
EVP, Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-07-06$3.95/sh+3,890$15,366476,827 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-07-063,8905,000 total
    Exercise: $3.95Exp: 2029-03-13Common Stock (3,890 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.

Issuer

Rain Therapeutics Inc.

CIK 0001724979

Entity typeother

Related Parties

1
  • filerCIK 0001856681

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 6:02 PM ET
Size
6.9 KB